Free Trial

Tilray Brands (TLRY) Competitors

C$2.45
-0.03 (-1.21%)
(As of 05/31/2024 ET)

TLRY vs. APHA, BHC, CRON, THCX, WEED, GUD, ACB, FIRE, CRDL, and OGI

Should you be buying Tilray Brands stock or one of its competitors? The main competitors of Tilray Brands include Aphria (APHA), Bausch Health Companies (BHC), Cronos Group (CRON), Hydropothecary (THCX), Canopy Growth (WEED), Knight Therapeutics (GUD), Aurora Cannabis (ACB), Supreme Cannabis (FIRE), Cardiol Therapeutics (CRDL), and Organigram (OGI). These companies are all part of the "drug manufacturers - specialty & generic" industry.

Tilray Brands vs.

Aphria (TSE:APHA) and Tilray Brands (TSE:TLRY) are both mid-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, earnings, profitability, community ranking, institutional ownership, media sentiment, analyst recommendations, valuation and risk.

Aphria received 381 more outperform votes than Tilray Brands when rated by MarketBeat users. Likewise, 68.04% of users gave Aphria an outperform vote while only 0.00% of users gave Tilray Brands an outperform vote.

CompanyUnderperformOutperform
AphriaOutperform Votes
381
68.04%
Underperform Votes
179
31.96%
Tilray BrandsOutperform Votes
No Votes
Underperform Votes
7
100.00%

In the previous week, Tilray Brands' average media sentiment score of 0.00 equaled Aphria'saverage media sentiment score.

Company Overall Sentiment
Aphria Neutral
Tilray Brands Neutral

12.2% of Tilray Brands shares are owned by institutional investors. 1.2% of Tilray Brands shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Tilray Brands has a consensus price target of C$2.95, indicating a potential upside of 20.41%.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aphria
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Tilray Brands
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Aphria has a net margin of 0.00% compared to Aphria's net margin of -47.35%. Tilray Brands' return on equity of 0.00% beat Aphria's return on equity.

Company Net Margins Return on Equity Return on Assets
AphriaN/A N/A N/A
Tilray Brands -47.35%-9.69%-1.67%

Tilray Brands has higher revenue and earnings than Aphria. Tilray Brands is trading at a lower price-to-earnings ratio than Aphria, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AphriaC$611.06M0.00-C$637.39M-C$2.01N/A
Tilray BrandsC$743.25M2.72-C$351.95M-C$0.60-4.08

Summary

Tilray Brands beats Aphria on 6 of the 11 factors compared between the two stocks.

Get Tilray Brands News Delivered to You Automatically

Sign up to receive the latest news and ratings for TLRY and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TLRY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TLRY vs. The Competition

MetricTilray BrandsDrug Manufacturers IndustryMedical SectorTSE Exchange
Market CapC$2.02BC$1.19BC$5.12BC$5.43B
Dividend YieldN/A3.07%2.75%5.57%
P/E Ratio-4.08545.16133.3520.78
Price / Sales2.729,249.212,429.342,535.26
Price / Cash5.9510.4335.1879.97
Price / Book0.568.195.533.53
Net Income-C$351.95MC$159.95MC$105.96MC$286.85M
7 Day Performance-2.78%0.11%1.14%-0.17%
1 Month Performance-11.23%-1.13%1.43%2.81%
1 Year Performance6.06%37.12%4.09%30.38%

Tilray Brands Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
APHA
Aphria
0 of 5 stars
N/AN/AN/AC$5.24BC$611.06M-8.231,200
BHC
Bausch Health Companies
0.2745 of 5 stars
C$8.95
+4.2%
C$9.00
+0.6%
-19.7%C$3.28BC$8.97B-5.3020,270High Trading Volume
CRON
Cronos Group
0 of 5 stars
C$3.54
+3.5%
C$3.18
-10.2%
+47.5%C$1.35BC$93.03M-18.63356
THCX
Hydropothecary
0 of 5 stars
C$5.30
+6.6%
N/A+0.0%C$949.11MN/A0.00N/AHigh Trading Volume
WEED
Canopy Growth
0.0439 of 5 stars
C$11.59
-1.6%
C$3.78
-67.4%
+925.7%C$869.83MC$362.24M-0.542,700Analyst Forecast
GUD
Knight Therapeutics
0.8122 of 5 stars
C$6.00
+3.6%
C$6.75
+12.5%
+25.0%C$608.28MC$332.21M-37.50725High Trading Volume
ACB
Aurora Cannabis
0.0763 of 5 stars
C$8.42
-0.5%
C$2.26
-73.1%
+1,138.2%C$459.23MC$275.88M-0.111,130
FIRE
Supreme Cannabis
0 of 5 stars
N/AN/AN/AC$259.40MC$53.29M-10.97400
CRDL
Cardiol Therapeutics
0 of 5 stars
C$3.57
+1.1%
N/A+292.3%C$246.33MN/A-7.60N/A
OGI
Organigram
2.9418 of 5 stars
C$2.34
-0.4%
C$3.76
+60.6%
+358.8%C$241.02MC$149.21M-0.93984

Related Companies and Tools

This page (TSE:TLRY) was last updated on 6/1/2024 by MarketBeat.com Staff

From Our Partners